Error loading player: No playable sources found

Player size: small large

The Future is Allogeneic - Translating a CRISPR Platform into Gene-Edited Cell Therapies

Date

March 9, 2021

Speaker

Rachel E. Haurwitz, PhD

Caribou Biosciences, Inc.

Tracks

Therapeutics I: Ex Vivo Editing

Related Products

Thumbnail for [Joint Session] Career Roundtable

[Joint Session] Career Roundtable

Thumbnail for [NOT AVAILABLE ON DEMAND] Short Talk: Knockout of NKG2A by CRISPR in Human NK Cells Enhance their Cytotoxic Activity Against Solid Tumors

[NOT AVAILABLE ON DEMAND] Short Talk: Knockout of NKG2A by CRISPR in Human NK Cells Enhance their Cytotoxic Activity Against Solid Tumors

Thumbnail for Short Talk: Fast and Efficient Generation of TRAC-integrated CAR T Cells without Viruses

Short Talk: Fast and Efficient Generation of TRAC-integrated CAR T Cells without Viruses

Thumbnail for Short Talk: Optimizing Stem Cell Lines for in vitro-derived Beta Cell Therapeutics via Genome-wide CRISPR Knock-out Screening

Short Talk: Optimizing Stem Cell Lines for in vitro-derived Beta Cell Therapeutics via Genome-wide CRISPR Knock-out Screening

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.